about
Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wallAntisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humansIncreased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events.Modulation of atherosclerosis in mice by Toll-like receptor 2An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice.Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.Angiotensinogen Exerts Effects Independent of Angiotensin II.Toll-like receptors and atherosclerosis: key contributors in disease and health?Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr-/- miceCD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation.17beta-estradiol reduces tumor necrosis factor-alpha-mediated LDL accumulation in the artery wall.Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17 beta-estradiol.Direct visualization of lipid deposition and reverse lipid transport in a perfused artery : roles of VLDL and HDL.Chronic estradiol treatment attenuates stiffening, glycoxidation, and permeability in rat carotid arteries.Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury.Apolipoprotein E3- and nitric oxide-dependent modulation of endothelial cell inflammatory responses.Influence of folate on arterial permeability and stiffness in the absence or presence of hyperhomocysteinemia.Hyperhomocysteinemia increases arterial permeability and stiffness in mice
P50
Q28567245-70BAD964-1B48-4951-8022-F7915B54BA6AQ28575302-2B0534FD-2E90-44C7-9DDD-E714018130F0Q33318184-A474F37B-EDE2-4676-B940-0D8C45F3E658Q34063165-C3079D25-9C8F-4FF4-A50B-030FDB81DD02Q34074513-ADC549DA-0EC8-475D-A675-C57B362C6F64Q34776352-C91FB263-AA8C-4874-8B65-5B24DB9C8563Q35086449-8D2CFDBC-46EE-4018-8518-6229226890EAQ36385359-4F630D15-9A00-45EC-BC98-1BC91E5DB507Q36520564-80DD2E9E-083F-4F99-B2F3-20252BC093B7Q36557759-A24B9DEE-567F-477B-899C-32CB3400BB1FQ37163010-0E4DBF46-F6D3-4027-B178-B5A38AEF07D5Q40256254-10207109-4F07-4178-9EA2-F2D12BC9977EQ41610868-97B74DAF-B8EC-4B95-B3A7-74911CD4E011Q41644594-F2085D6C-E8A6-404F-982B-40FD0F38FE74Q41730058-AC3A6F0B-11C7-4368-AE8E-8A479A00B576Q43773182-C6814924-E5F5-43B0-BB2B-09070A17F1FAQ44068479-E34334EB-BE2C-49E8-A1E0-681672D86F53Q46304082-6FC07B62-760B-40E8-AE9E-A9BA78D89EE8Q46902318-209CBBB3-C040-48D8-8F7F-9B7B879C2CD6Q79774410-9BA5820A-BEBE-4ED8-B5F6-02C8CB27FDCE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adam E Mullick
@ast
Adam E Mullick
@en
Adam E Mullick
@es
Adam E Mullick
@nl
Adam E Mullick
@sl
type
label
Adam E Mullick
@ast
Adam E Mullick
@en
Adam E Mullick
@es
Adam E Mullick
@nl
Adam E Mullick
@sl
prefLabel
Adam E Mullick
@ast
Adam E Mullick
@en
Adam E Mullick
@es
Adam E Mullick
@nl
Adam E Mullick
@sl
P106
P21
P31
P496
0000-0003-4600-961X